In this paper, we analyze the initial and long-term results at 10 years, such as clinical outcome, duration of response, toxicity and survival of 44 HCL pts uniformly treated with a single 7-day ...
Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. Patients with advanced malignancies were eligible. There were two treatment cycles; ...
Improved survival for patients with acute myelogenous leukemia. 2-chlorodeoxyadenosine (2-CdA; cladribine) is a purine analog with activity in patients with chronic lymphocytic leukemia (CLL) who fail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results